FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009282612> ?p ?o ?g. }

• W2009282612 endingPage "938" @default.
• W2009282612 startingPage "931" @default.
• W2009282612 abstract "Background Nevirapine (NVP) is often prescribed once daily in clinical practice in combination with a once daily nucleoside backbone. We investigated the relationship of NVP dosing with safety and efficacy. Methods Patients from the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort study, Canadian HAART Observational Medical Evaluation and Research (HOMER) cohort and Swiss HIV Cohort Study (SHCS) using NVP-based combination therapy either once daily or twice daily were included. Risk factors for discontinuing NVP because of hypersensitivity reactions (HSRs) were investigated using multivariate logistic regression. Risk factors for virological failure 96 weeks after NVP initiation were identified using logistic regression and Cox models. Results Of 5,636 patients (774 once daily and 4,862 twice daily), 268 (4.8%) discontinued NVP because of HSR between 2 and 18 weeks. Logistic regression showed that, compared with patients with detectable HIV type-1 (HIV-1) RNA starting twice-daily NVP, there was a significantly higher risk of discontinuation of once-daily NVP because of HSR in patients with detectable HIV-1 RNA at the start of NVP (odds ratio [OR] 1.52; P=0.04), whereas the risk was actually significantly lower in patients starting once-daily NVP with undetectable HIV-1 RNA (OR 0.44; P=0.04). Cox models showed that risk of virological failure was not different for twice- versus once-daily NVP in treatment-naive patients (twice-daily versus once-daily hazard ratio [HR] 1.01; P=0.95), treatment- experienced patients experiencing treatment failure (twice-daily versus once-daily HR 1.22; P=0.30) or patients with undetectable HIV-1 RNA simplifying treatment with NVP (twice-daily versus once-daily HR 1.29; P=0.30). Conclusions Initiation of a once-daily NVP-based regimen in patients with suppressed viraemia carries a low risk of treatment-limiting HSR. Once- or twice-daily NVP-based regimens appear to have similar antiretroviral efficacy." @default.
• W2009282612 created "2016-06-24" @default.
• W2009282612 creator A5001375239 @default.
• W2009282612 creator A5009780207 @default.
• W2009282612 creator A5018761768 @default.
• W2009282612 creator A5040946922 @default.
• W2009282612 creator A5044801510 @default.
• W2009282612 creator A5049128301 @default.
• W2009282612 creator A5059371192 @default.
• W2009282612 creator A5060213700 @default.
• W2009282612 creator A5062368847 @default.
• W2009282612 creator A5070365161 @default.
• W2009282612 creator A5074441717 @default.
• W2009282612 creator A5080147979 @default.
• W2009282612 creator A5082840819 @default.
• W2009282612 date "2009-10-01" @default.
• W2009282612 modified "2023-09-28" @default.
• W2009282612 title "Safety and Efficacy of Once-Daily Nevirapine Dosing: A Multicohort Study" @default.
• W2009282612 cites W1984124421 @default.
• W2009282612 cites W1984745693 @default.
• W2009282612 cites W1987146942 @default.
• W2009282612 cites W2008209991 @default.
• W2009282612 cites W2018158288 @default.
• W2009282612 cites W2025722763 @default.
• W2009282612 cites W2042638966 @default.
• W2009282612 cites W2054105441 @default.
• W2009282612 cites W2064206379 @default.
• W2009282612 cites W2104810332 @default.
• W2009282612 cites W2114793603 @default.
• W2009282612 cites W2119433625 @default.
• W2009282612 cites W2124431973 @default.
• W2009282612 cites W2130575607 @default.
• W2009282612 cites W2141776019 @default.
• W2009282612 cites W2152293167 @default.
• W2009282612 cites W2262384877 @default.
• W2009282612 cites W2321852728 @default.
• W2009282612 cites W2406018938 @default.
• W2009282612 cites W4992121 @default.
• W2009282612 doi "https://doi.org/10.3851/imp1418" @default.
• W2009282612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19918097" @default.
• W2009282612 hasPublicationYear "2009" @default.
• W2009282612 type Work @default.
• W2009282612 sameAs 2009282612 @default.
• W2009282612 citedByCount "20" @default.
• W2009282612 countsByYear W20092826122012 @default.
• W2009282612 countsByYear W20092826122013 @default.
• W2009282612 countsByYear W20092826122014 @default.
• W2009282612 countsByYear W20092826122015 @default.
• W2009282612 countsByYear W20092826122016 @default.
• W2009282612 countsByYear W20092826122017 @default.
• W2009282612 countsByYear W20092826122018 @default.
• W2009282612 countsByYear W20092826122019 @default.
• W2009282612 countsByYear W20092826122020 @default.
• W2009282612 countsByYear W20092826122022 @default.
• W2009282612 crossrefType "journal-article" @default.
• W2009282612 hasAuthorship W2009282612A5001375239 @default.
• W2009282612 hasAuthorship W2009282612A5009780207 @default.
• W2009282612 hasAuthorship W2009282612A5018761768 @default.
• W2009282612 hasAuthorship W2009282612A5040946922 @default.
• W2009282612 hasAuthorship W2009282612A5044801510 @default.
• W2009282612 hasAuthorship W2009282612A5049128301 @default.
• W2009282612 hasAuthorship W2009282612A5059371192 @default.
• W2009282612 hasAuthorship W2009282612A5060213700 @default.
• W2009282612 hasAuthorship W2009282612A5062368847 @default.
• W2009282612 hasAuthorship W2009282612A5070365161 @default.
• W2009282612 hasAuthorship W2009282612A5074441717 @default.
• W2009282612 hasAuthorship W2009282612A5080147979 @default.
• W2009282612 hasAuthorship W2009282612A5082840819 @default.
• W2009282612 hasConcept C126322002 @default.
• W2009282612 hasConcept C142462285 @default.
• W2009282612 hasConcept C151956035 @default.
• W2009282612 hasConcept C156957248 @default.
• W2009282612 hasConcept C201903717 @default.
• W2009282612 hasConcept C203014093 @default.
• W2009282612 hasConcept C207103383 @default.
• W2009282612 hasConcept C2777288759 @default.
• W2009282612 hasConcept C2778715236 @default.
• W2009282612 hasConcept C2779130552 @default.
• W2009282612 hasConcept C2993143319 @default.
• W2009282612 hasConcept C3013748606 @default.
• W2009282612 hasConcept C44249647 @default.
• W2009282612 hasConcept C50382708 @default.
• W2009282612 hasConcept C71924100 @default.
• W2009282612 hasConcept C72563966 @default.
• W2009282612 hasConceptScore W2009282612C126322002 @default.
• W2009282612 hasConceptScore W2009282612C142462285 @default.
• W2009282612 hasConceptScore W2009282612C151956035 @default.
• W2009282612 hasConceptScore W2009282612C156957248 @default.
• W2009282612 hasConceptScore W2009282612C201903717 @default.
• W2009282612 hasConceptScore W2009282612C203014093 @default.
• W2009282612 hasConceptScore W2009282612C207103383 @default.
• W2009282612 hasConceptScore W2009282612C2777288759 @default.
• W2009282612 hasConceptScore W2009282612C2778715236 @default.
• W2009282612 hasConceptScore W2009282612C2779130552 @default.
• W2009282612 hasConceptScore W2009282612C2993143319 @default.
• W2009282612 hasConceptScore W2009282612C3013748606 @default.
• W2009282612 hasConceptScore W2009282612C44249647 @default.
• W2009282612 hasConceptScore W2009282612C50382708 @default.

• next